Dr. Reddy's Hyderabad facility becomes part of Global Lighthouse Network of World Economic Forum

India Pharma Outlook Team | Wednesday, 12 October 2022

 India Pharma Outlook Team

Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced that its largest manufacturing facility in Bachupally, Hyderabad, has joined Global Lighthouse Network (GLN) of the World Economic Forum (WEF). With this honour, the facility became part of GLN, a community of over 100 manufacturers that are showing leadership in applying Fourth Industrial Revolution (Industry 4.0 or 4IR) technologies to drive impact in productivity, workforce engagement, sustainability, and supply chain resilience. GLN is a WEF initiative in collaboration with McKinsey & Company. Factories and value chains that join GLN are designated by an independent panel of experts. The journey began four years ago when Dr. Reddy’s embarked on an ambitious programme to ‘digitise its core’.

This involved upgrade of infrastructure and digitisation of processes for robust and comprehensive data capture. Real-time data and insights laid the foundation for Project ‘OpsNext’ which was initiated two years ago to transform the plant into an Industry 4.0-driven ‘Lighthouse’ factory as defined by the WEF. The site saw the deployment of six of the eight technologies of 4IR – Advanced Analytics, Digital Twins, Robotic Process Automation, Augmented/Virtual/Mixed Reality, Digital Performance Management and Industrial Internet of Things (IIoT). The OpsNext team identified 40+ business results linked use cases impacting various aspects of productivity such as customer service, quality, energy consumption, sustainability, equipment efficiency and people productivity.

The company also invested heavily in building people capabilities such as digital and analytics translators, data scientists and data engineers. In response to business scenarios of price erosion, sustainable manufacturing practices, need for constant vigilance and maintenance of uncompromising standards of quality, the journey has already yielded significant results at the site – 43 per cent manufacturing cost improvement, 30 per cent reduction in production lead time, 41 per cent energy consumption reduction, and significant dip in quality deviations. Sanjay Sharma, global head of manufacturing, Dr. Reddy’s said, “The successful inclusion of our 25-year-old site in Hyderabad as a ‘Digital Lighthouse’ factory is a big milestone in our productivity improvement journey.

We have seen significant financial and operational impact from the journey. We are in the process of scaling and replicating this to the rest of our manufacturing network. Dr. Reddy’s aspires to be the most efficient pharma operations in the world. Our productivity improvement and digitalisation efforts are key to staying competitive, meeting business imperatives, and meeting our ambitious ESG goals. Building such ‘factories of the future’ is integral to innovation and to build healthcare of the future. One of the most important outcomes is that our top talent and young leaders want to be a part of this aspirational journey. This collaborative and cross-functional effort truly helps us fulfil our purpose of ‘Good Health Can’t Wait’.”

© 2024 India Pharma Outlook. All Rights Reserved.